The US Meals and Drug Administration has licensed the usage of the Pfizer-BioNTech COVID-19 vaccine in adolescents between the ages of 12 to 15, the company introduced Monday night.
Within the announcement, performing FDA Commissioner Janet Woodcock referred to as the authorization “a big step within the struggle in opposition to the COVID-19 pandemic” that can convey the nation “nearer to returning to a way of normalcy and to ending the pandemic.”
Peter Marks, director of the FDA’s Middle for Biologics Analysis and Analysis, echoed that sentiment. He referred to as the flexibility to vaccinate kids and youths “a essential step” within the struggle in opposition to COVID-19.
Learn 7 remaining paragraphs | Feedback